Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant

Journal of Occupational and Environmental Medicine

Volumn 43, Issue 3, 2001, Pages 231-237

  Newman, Lee S ^a,b   Mroz, Margaret M ^a   Maier, Lisa A ^a,b   Daniloff, Elaine M ^a   Balkissoon, Ronald ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERYLLIUM;

ADULT; ARTICLE; BERYLLIOSIS; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PERIODIC MEDICAL EXAMINATION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SENSITIZATION;

STAPHYLOCOCCUS PHAGE 187;

EID: 0035077814     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-200103000-00011     Document Type: Article

References (20)

1. Beryllium disease
2. Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease
3. Significance of the blood beryllium lymphocyte proliferation test (BeLPT)
4. Screening blood test identifies subclinical beryllium disease
5. Beryllium disease screening in the ceramics industry: Blood test performance and exposure-disease relations
6. Epidemiology of beryllium sensitization and disease in nuclear workers
7. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plan
8. 3
9. Rocky Flats beryllium health surveillance
10. Chronic beryllium disease: From the workplace to cellular immunology, molecular immunogenetics, and back
11. Delayed chemical pneumonitis in workers exposed to beryllium compounds
12. Epidemiological aspects of beryllium-induced nonmalignant lung disease: A 30-year update
13. The pulmonary toxicity of beryllium
14. Aerosols generated during beryllium machining
15. Beryllium particulate exposure and disease relations in a beryllium machining plant
16. Pathologic and immunologic alterations in early stages of beryllium disease: Re-examination of disease definition and natural history
17. HLA-DPB1 glutamate 69: A genetic marker of beryllium disease
18. Interaction of genetic and exposure factors in the prevalence of berylliosis
19. Early pulmonary physiologic abnormalities in beryllium disease